SciFounders

Excited to share details of what we are working on @nudge for the first time today. Our mission is to improve everyday life by developing the best technologies for interfacing with the brain.

We started collecting applications for SciFounder Fellowship!! For mission-driven hard tech founders Up to $1M to get started Direct mentorship from us for 1 year+ Funding decisions within weeks scifounders.com Deadline is 2/28 - 11:59 pm PST

I've got some news to share. @earthaiexplore is now our largest investment! I've got a LOT of thoughts to share on why I'm so excited about Earth AI but I'll write about that another time. For now I'll just say that I'm so flippin' proud of Roman, Isabella, & the whole EAI team.…

Over 700 signups for our workshop on how to secure biotech partnerships with @CRISPR_LuCas. Still time to register! lu.ma/89bnm9jk

For all you gene editing scientists out there, I highly encourage you to join this conversation. We've buried our head in the sand for too long on heritable editing, paving the way for reckless individuals to pave their own path

Interesting: the big swings in biotech funding have largely been driven by generalist funds -- many leaned heavily into biotech in 2018–2019 and now seem to be pulling back. Specialist funds have continued deploying at a steadier pace.

Partnerships are becoming more important than ever for biotech startups. @SciFounders is hosting a free, open workshop on how to land partnerships and how to make them work. 350+ sign-ups, but there’s still time to join.

The crummiest part of venture capital is having to tell people no. We at @SciFounders often need to make tough decisions. I went back to our notes on the last ~500 startups we met and could boil down our feedback to 7 main factors that I think are critical.

📅 Save the date for our Biotech Partnerships workshop: June 11 | 9–10 AM PT Partnerships are more important than ever in today’s financial environment. That’s why our next session will focus on how to make them work. Lucas Harrington has built partnerships at Mammoth that have…

Check out what we're working on at Olio Labs! 70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men. What is driving this difference? We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out:

~450 applications received for SciFounder Fellowship! Going to take us some time to review -- sorry if delays in getting back. You can still apply late if you want/need on our website (up to $1MM for health technology ideas).

Partnerships have been crucial to Mammoth's success, delivering $200M+ in upfront payments. I wrote up the guide I wish someone had given me when I started out. Hope this helps others close the right deal! 🧵 and link:

We have over 200 sign-ups for our info session about SciFounder Fellowship but still a few places left if you want to join and learn more about the program, the funding we provide (~$1MM), and how we work with founders. lu.ma/rksb1806 See you soon!

This was fun!! Over 200 people joined our workshop on fundraising for founder-led biotech. Recording is here: youtu.be/-cvMT1KJ5OE Let's do something similar for partnerships in biotech?? 👀 Please share so that many more founders can see!

Over 500 people have signed up for our fundraising workshop tomorrow. Not too late to join!! You can sign up here: forms.gle/yfvKHnibypK6UL…

Pluripotent stem-cell-derived therapies in clinical trials by year, colored by product type. Ocular and CNS lead due to low cell input requirements and immune privilege.

I've raised about $100 million for biotech projects at this point - fundraising can be really hard. I wrote up thoughts for newer biotech founders trying to raise in the new year (longer post at end) 🧵

The first SciFounder workshop will be about fundraising for founder-led biotech on the 22nd of January at 9 am PT, hosted by @mattkrisiloff Sign up here: forms.gle/YFNsoHvvp36dtk… Matt is the CEO of @Conception, was the Chief of Staff to Sam Altman, a founding member of OpenAI,…

We are still very excited to invest in platform companies!! I talked to 300+ bio founders in the last few months, and many think that only asset-focused companies are getting funded now. If there is a clear path to a solid pipeline there is a ton of value in platforms that are…

Something fascinating - surgeries are often hospitals' biggest money-makers, and it makes sense why. For so many major diseases, surgery is the best shot at a cure. Every surgical breakthrough leads to greater longevity.